Search Results

Displaying Results 1-1 of 1 "'INVA'"

Oct 21, 2025, 08:00 ET Antheia Appoints Eric d'Esparbes as Chief Financial Officer

focused biotherapeutics business and previously led its initial public offering in 2020. d'Esparbes also led the finance teams at Innoviva, Inc. (Nasdaq: INVA), Joule Unlimited, and AEI, Inc. "Antheia's success in bringing its technology to a commercial scale is a rare and impressive

More news about: Antheia


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.